Table 1.
Clinical data at the time point of renal biopsy
| Parameter | Value (reference range) | Parameter | Value (reference range) | Parameter | Value (reference range) |
|---|---|---|---|---|---|
| Hematological | Blood biochemistry | Immunological test | |||
| White blood cell count, /μL | 8100 (4000-8000) | Total protein, g/dL | 7.0 (6.7-8.3) | CH50, IU/mL | 77 (32-49) |
| Hemoglobin, g/dL | 15.6 (14-18) | Albumin, g/dL | 4.7 (3.9-4.9) | C3, mg/dL | 128 (65-135) |
| Platelets, ×104/μL | 14.1 (15-35) | Blood urea nitrogen, mg/dL | 30 (8-22) | C4, mg/dL | 28 (13-35) |
| Reticulocyte, % | 1.3 (0.2-2.8) | Creatinine, mg/dL | 2.98 (0.61-1.04) | IgG, mg/dL | 867 (870-1700) |
| eGFR, mL/min/1.73m2 | 27 (>60) | IgA, mg/dL | 197 (110-410) | ||
| Coagulation test | Cystatin C, mg/dL | 1.35 (0.63-0.95) | IgM, mg/dL | 56 (35-220) | |
| within normal range | Uric acid, mg/dL | 12.7 (2-7) | |||
| Creatinine kinase, mg/dL | 127 (60-287) | Antinuclear antibody, IU/mL | <40 (<40) | ||
| Urinalysis | Sodium, mmol/L | 139 (138-146) | MPO-ANCA, IU/mL | <1.0 (0-3.5) | |
| pH | 5.0 (4.5-8.0) | Potassium, mmol/L | 4.4 (3.6-4.9) | PR3-ANCA, IU/mL | <1.0 (0-3.5) |
| Specific gravity | 1.011 (1.005-1.025) | Chloride, mmol/L | 99 (99-109) | anti-GBM, U/mL | <2.0 (0-3) |
| Protein urea, g/g creatinine | <0.15 (<0.15) | Calcium, mg/dL | 9.2 (8.7-10.3) | ASO, IU/mL | <10 (0-239) |
| Red Blood Cell, /HPF | 1~4 (<5) | Glucose, mg/dL | 98 (70-109) | ASK | <20 (<20) |
| White Blood Cell, /HPF | 5~9 (<5) | Bilirubin totally, mg/dL | 2.9 (0.2-1.3) | cryoglobulin | negative |
| U-NAG, IU/L | 7.4 (0.7-11.2) | Bilirubin direct, mg/dL | 0.9 (0-0.3) | ||
| U-β2MG, μg/L | 10 (0-230) | AST, IU/L | 14 (13-33) | Haptoglobin, mg/dL | 183 (19-170) |
| U-α1MG, mg/L | 2.3 (1-15.5) | ALT, IU/L | 11 (8-42) | DAT | negative |
| L-FABP, μg/g creatinine | 0.81 (0-8.4) | LDH, IU/L | 313 (124-222) | ||
| Total cholesterol, mg/dL | 139 (128-219) | ||||
| Blood gas analysis | LDL cholesterol, mg/dL | 82 (70-139) | |||
| pH | 7.313 (6-8) | Triglyceride, mg/dL | 83 (30-149) | ||
| HCO3, mmol/L | 25.9 (0-99.9) | C-reactive protein, mg/dL | 1.9 (0-0.3) | ||
| Base excess, mmol/L | -1.1 (-99~99) | HbA1c, % | 5.3 (4.6-6.2) | ||
| Hemolysis test | |||||
| Ham test | negative | ||||
| erythrocyte fragility test | negative |
U-NAG Urinary N-acetyl-β-D-Glucosaminidase, U-β2MG Urinary beta2-microglobulin, U-α1MG Urinary alpha1-microglobulin, eGFR Estimated glomerular filtration rate, L-FABP, L-type fatty acid-binding protein, AST Aspartate amino transferase, ALT Alanine aminotransferase, LDH Lactate dehydrogenase, LDL Low density lipoprotein, HbA1c Hemoglobin A1c, Ig Immunoglobulin, MPO Myeloperoxidase, PR3 Proteinase, ANCA Anti-neutrophil cytoplasmic antibody, GBM Glomerular basement membrane, ASO Anti-streptolysin, ASK Anti-streptokinase antibody, DAT Direct antiglobulin test